Mission:
The Southern California Biomedical Council's Regulatory
Affairs Committee serves
as a forum for:
-
Networking among regulatory and clinical affairs professionals in the
Greater Los Angeles region,
-
Providing educational seminars focusing on
regulatory and clinical issues, and
-
Helping local firms, particularly startups, access resources to meet
regulatory compliance requirements.
Committee
Members (under construction):
-
Marvin Garret,
VP, Regulatory Affairs, Quality and Compliance, Ista
Pharmaceuticals
-
John Clapham,
Pres. & CEO, Pharmaceutical Services Corporation
-
Susan Bond, Regulatory Specialists, Inc.
-
R. J. O'Meara,
Director, Global Legislative & Government Affairs,
Beckman-Coulter Inc.
-
Julie Finke, Sr. Director, Quality Assurance
Diagnostics, Novartis Vaccines & Diagnostics
-
Bob Mehta, Sr. Regulatory Compliance Manager,
Edwards Lifesciences
-
Michael Swit, Vice
President, The Weinberg Group Inc.
-
Syed
Ali, QA Manager, Allergan
-
Aiying Sun, Manager, Quality Assurance Validation, Siemens Healthcare Diagnostics
-
Evan Siegel, M.Phil., Ph.D., President and CEO, Ground Zero Pharmaceuticals
-
James Barquest, Ph.D., Director of Regulatory
Affairs, Ground Zero Pharmaceuticals
-
Kristin Houser, Director, Employee Training Institute, College of the Canyons
-
Frances
Richmond, Ph.D., Director, Regulatory Science Program, USC
School of Pharmacy
- Prithul Bom, Account
Executive, RCRI, Inc.
- Jennifer
Marrone, Exec VP, RCRI, Inc.
|